Comparison of assays for anti‐HBc in blood donors
- 8 July 1988
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 28 (4) , 389-391
- https://doi.org/10.1046/j.1537-2995.1988.28488265275.x
Abstract
Testing for anti-HBc has been recommended for use as a paradoxical or surrogate marker of carriers of non-A, non-B hepatitis. Serial sampling on a pool of 35,600 donors was done and those donors found to be repeatedly reactive by EIA method were retested using RIA methodology. Of 1367 donors found to be repeatedly reactive by EIA method, only 984 were confirmed by RIA. Those found to be reactive by EIA only were allowed to donate blood again, with only three of them becoming positive by both EIA and RIA on subsequent donations. The majority of these donors (107 out of 151) reverted to EIA negative status. Therefore, the finding of a positive anti-HBc by EIA method that could not be repeated by RIA method is not an early reproducible sign of anti-HBc reactive status.This publication has 5 references indexed in Scilit:
- A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitisTransfusion, 1987
- Evaluation of routine anti‐HBc screening of volunteer blood donors: a questionable surrogate test for non‐A, non‐B hepatitisTransfusion, 1987
- Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated BloodAnnals of Internal Medicine, 1986
- Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion RecipientsAnnals of Internal Medicine, 1984
- Indirect Tests to Detect the Non-A, Non-B Hepatitis Carrier StateAnnals of Internal Medicine, 1984